WorldCat Identities

Lucey, Michael R.

Overview
Works: 21 works in 40 publications in 2 languages and 1,579 library holdings
Roles: Author, Editor, Contributor, Speaker
Publication Timeline
.
Most widely held works by Michael R Lucey
Liver transplantation : practice and management by Michael R Lucey( )

8 editions published between 1994 and 2018 in English and Undetermined and held by 1,314 WorldCat member libraries worldwide

The purpose of this volume is to provide a short, didactic handbook for those clinicians (medical, surgical, nursing and others) who are involved in the care and management of people who may, are or have undergone liver transplantation
Liver transplantation & the alcoholic patient : medical, surgical, and psychosocial issues by Michael R Lucey( Book )

5 editions published in 1994 in English and held by 116 WorldCat member libraries worldwide

Alcoholic liver disease by Michael R Lucey( Visual )

4 editions published in 2011 in English and held by 57 WorldCat member libraries worldwide

Reviews the biochemistry and the metabolism of alcohol, the mechanisms behind the accumulation of fat in the liver, clinical and laboratory features of alcoholic hepatitis and how nutritional therapy can aid patients with alcohol hepatitis
Liver Transplantation (Vademecum) by Abraham Shaked( Book )

1 edition published in 2003 in Undetermined and held by 37 WorldCat member libraries worldwide

Liver transplantation : clinical assessment and management by James Neuberger( )

5 editions published in 2021 in English and held by 33 WorldCat member libraries worldwide

"Welcome to the second edition of Liver Transplantation. Since the first edition, there have been many changes in the management of patients with liver disease, both before and after transplantation and this new edition reflects this. As with the first edition, the aim of the volume is to provide a concise, practical and authoritative guide for junior medical staff and other health professionals working in liver transplant units, for health care professionals looking after those patients with liver disease who are or may become liver transplant candidates and those following liver transplantation. We have expanded both the number and reach of authors, with consequent increase in chapters. We have sought to represent the breadth of liver transplant medicine across Europe and North America, while recognizing also the role of liver transplantation in the rest of the world. We appreciate that this means some duplication and occasional divergence of views. We have intentionally retained these so that each chapter is entire of itself and the reader understands where there is uncertainty. We are very grateful to the authors who have written and revised their contributions during the height of the Covid pandemic. We are grateful to those at Wiley Blackwell, especially Jennifer Seward and Pri Gibbons, for the help and patience and, most importantly to our partners and children who have been patient with us during the preparation of this second edition"--
Alcoholic liver disease by Michael R Lucey( )

1 edition published in 2011 in English and held by 2 WorldCat member libraries worldwide

Genetic Variations Linked to Hepatocellular Carcinoma: Personalized Medicine Takes a Step Forward by Parul D Agarwal( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Alcohol and Substance Abuse( )

1 edition published in 2009 in English and held by 2 WorldCat member libraries worldwide

A family with Multiple Endocrine Neoplasia Type 1 by Michael R Lucey( )

1 edition published in 1983 in English and held by 2 WorldCat member libraries worldwide

High-Dose Acyclovir for Cytomegalovirus Prophylaxis in Seropositive Abdominal Transplant Recipients( )

in English and held by 1 WorldCat member library worldwide

Background: Following abdominal solid organ transplant (aSOT), valganciclovir (VGC) is recommended for cytomegalovirus (CMV) prophylaxis. This agent is associated with efficacy concerns, toxicity, and emergence of ganciclovir resistance. Objective: To evaluate the incidence of high-dose acyclovir (HD-A) prophylaxis failure in seropositive aSOT recipients (R+). Methods: This was a retrospective, single-center study of R+ transplanted without lymphocyte-depleting induction between January 1, 2000, and June 30, 2013, discharged with 3 months of HD-A prophylaxis (800 mg 4 times daily). The primary outcome was incidence of prophylaxis failure. Secondary outcomes were incidence of biopsy-proven tissue-invasive disease and prophylaxis failure for each allograft subgroup. Results: A total of 1525 patients met inclusion criteria: 944 renal (RTX), 108 simultaneous pancreas-kidneys (SPK), 462 liver (LTX), and 11 pancreas (PTX) transplant recipients. The composite rate of HD-A prophylaxis failure was 7%; incidence of tissue-invasive disease was 0.4%. Failure rates were 4.5%, 6.1%, 11%, and 20% in the RTX, SPK, LTX, and PTX populations, respectively; tissue-invasive disease rates were 0.2%, 0%, 0.7%, and 10%. Failure occurred more frequently in the LTX and PTX populations (P < 0.0001, HR = 2.6; P = 0.04 HR = 4.4). Incidence of tissue-invasive disease was minimal and not different in the RTX, LTX and SPK populations (P = 0.34). When evaluating recipients of seronegative allografts (D−), the composite failure rate was 3.4% with no significant difference between allograft subgroups (P = 0.45). Conclusion: HD-A may be a reasonable prophylaxis alternative for D−/R+ recipients, in the absence of lymphocyte-depleting induction, if low incidence viremia is tolerable. Future studies are needed to determine the long-term impact of CMV viremia in the setting of this prophylaxis approach
Alcoholic Liver Disease, An Issue of Clinics in Liver Disease, E-Book by Norman L Sussman( )

1 edition published in 2018 in English and held by 1 WorldCat member library worldwide

Liver disease( Recording )

2 editions published in 2007 in English and held by 1 WorldCat member library worldwide

Alkoholowe zapalenie wątroby by Michael R Lucey( )

1 edition published in 2010 in Polish and held by 1 WorldCat member library worldwide

Substance use disorders before and after liver transplantation( )

1 edition published in 2017 in English and held by 1 WorldCat member library worldwide

Abstract : Watch a video presentation of this article Watch the interview with the author
Therapeutic challenges in liver transplantation: hepatocellular carcinoma by Transplant Course( Book )

1 edition published in 2007 in English and held by 1 WorldCat member library worldwide

Impact of behaviors (smoking, treatment adherence, exercise, alcohol) on allograft function and outcomes( )

1 edition published in 2017 in English and held by 1 WorldCat member library worldwide

Multidisciplinary Management of Hepatocellular Carcinoma Improves Access to Therapy and Patient Survival( )

1 edition published in 2017 in English and held by 1 WorldCat member library worldwide

Abstract : Background: Given the complexity of managing hepatocellular carcinoma (HCC), it is widely accepted that a multidisciplinary team approach (tumor boards) offers the best approach to individualize therapy. The aim of this study was to determine utilization of therapies and outcomes for patients with HCC, comparing those managed through our multidisciplinary tumor board (MDTB) to those who were not. Methods: A database analysis of all patients with HCC managed through our MDTB, from 2007 until 2011, was performed. A database of all patients with HCC from 2002 to 2011, not managed through MDTB, was similarly created. Results: A total of 306 patients with HCC, from 2007 to 2011 were managed through our MDTB, in comparison with 349 patients, from 2002 to 2011 who were not. There were no significant differences in baseline demographic data or model for end-stage liver disease at presentation. Patients managed through MDTB were more likely to present at an earlier tumor stage and with lower serum alpha fetoprotein (AFP) (P =0.007). The odds of receiving any treatment for HCC was higher in patients managed through MDTB (odds ratio, 2.80; 95% confidence interval, 1.71-4.59; P <0.0001) independent of model for end-stage liver disease score, serum AFP, and tumor stage. There was significantly greater survival of patients managed through MDTB (19.1±2.5 vs. 7.6±0.9 mo, P <0.0001). Independent predictors for improved survival included management through MDTB, receipt of any HCC treatment, lower serum AFP, receipt of liver transplant, and T2 tumor stage. Conclusions: Patients with HCC managed through a MDTB had significantly higher rates of receipt of therapy and improved survival compared with those who were not
Alcoholic liver disease by Michael R Lucey( )

1 edition published in 2011 in English and held by 1 WorldCat member library worldwide

 
moreShow More Titles
fewerShow Fewer Titles
Audience Level
0
Audience Level
1
  General Special  
Audience level: 0.10 (from 0.01 for Genetic Va ... to 0.99 for Liver tran ...)

Liver transplantation : practice and management
Covers
Liver transplantation : clinical assessment and management
Alternative Names
Michael R. Lucey American gastroenterologist and researcher

Michael R. Lucey wetenschapper

Languages
English (36)

Polish (1)